Publications

Journal Article
Research Support, Non-U.S. Gov't
Ppublish 116 citations
Electronic publication date
December 22, 2006

View on Pubmed.gov 16980297 | View on doi.org 10.1074/jbc.M60...

Mdm2-mediated NEDD8 modification of TAp73 regulates its transactivation function.

Search for publications in this journal J Biol Chem - 281(45):34096-103

Abstract

Mutations in p73 are rare in cancer. Emerging evidence suggests that the relative expression of various p73 isoforms may contribute to tumorigenesis. Alternative promoters and N-terminal splicing result in the transcription and processing of either full-length (TA) or N-terminally truncated (deltaN) p73 isoforms. TAp73 possesses pro-apoptotic functions, while deltaNp73 has anti-apoptotic properties via functional inhibition of TAp73 and p53. Here, we report that TAp73, but not deltaNp73, is covalently modified by NEDD8 under physiologic conditions in an Mdm2-dependent manner. Co-expression of NEDP1, a cysteine protease that specifically cleaves NEDD8 conjugates, was shown to deneddylate TAp73. In addition, blockage of the endogenous NEDD8 pathway increased TAp73-mediated transactivation of p53- and p73-responsive promoter-driven reporter activity, and in conjunction, neddylated TAp73 species were found preferentially in the cytoplasm. These results suggest that Mdm2 attenuates TAp73 transactivation function, at least in part, by promoting NEDD8-dependent TAp73 cytoplasmic localization and provide the first evidence of a covalent post-translational modification exclusively targeting the TA isoforms of p73.

References

No references provided.

Cited by 116 citations (total)

Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't

Suppression of hypoxia-inducible factor 2alpha restores p53 activity via Hdm2 and reverses chemoresistance of renal carcinoma cells.

Electronic publication date December 22, 2009

Search for publications in this journal Cancer Res

Andrew M Roberts [...] Michael Ohh et al.

p53 mutations are rarely detected in clear cell renal cell carcinoma (CCRCC), but, paradoxically, these tumors remain highly resistant to...

Journal Article Research Support, Non-U.S. Gov't

Oncolytic targeting of renal cell carcinoma via encephalomyocarditis virus.

Electronic publication date November 5, 2010

Search for publications in this journal EMBO Mol Med

Frederik C Roos [...] Michael Ohh et al.

Apoptosis is a fundamental host defence mechanism against invading microbes. Inactivation of NF-kappaB attenuates encephalomyocarditis virus (EMCV) virulence by triggering...

Conflict of interest statement

No conflict of interest statement provided.

MeSH

Specialties

Substances